Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 7/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25657080 | 0.79 | ALDH1A1 (0.34) | ALDH1A1CA2MAPK1CA1TDP1 | |
| SCHEMBL11809231 | 0.74 | CA2 (0.54) | CA2MAPK1CA1TDP1 | |
| SCHEMBL11817761 | 0.72 | ALDH1A1 (0.46) | ALDH1A1CA2MAPK1CA1TDP1 | |
| SCHEMBL3093612 | 0.72 | ALDH1A1 (0.42) | ALDH1A1CA2MAPK1CA1TDP1 | |
| SCHEMBL18664275 | 0.72 | ALDH1A1 (0.42) | ALDH1A1CA2MAPK1CA1TDP1 | |
| SCHEMBL28520590 | 0.72 | — | — | |
| SCHEMBL598482 | 0.71 | ALDH1A1 (0.40) | ALDH1A1CA2MAPK1CA1TDP1 | |
| SCHEMBL30299060 | 0.71 | ALDH1A1 (0.40) | ALDH1A1CA2MAPK1CA1TDP1 | |
| SCHEMBL11818913 | 0.70 | ALDH1A1 (0.43) | ALDH1A1CA2MAPK1CA1TDP1 | |
| Hydrochloric Acid SCHEMBL30528602 | 0.70 | ALDH1A1 (0.41) | ALDH1A1CA2MAPK1CA1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025356-A1 | COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025356-A1 | COMPOSITION, LAYER INCLUDING THE COMPOSITION, LIGHT-EMITTING DEVICE INCLUDING THE COMPOSITION, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | LAGE3, ITK, TEC | ALDH1A1 4035/4885CA2 4533/4885MAPK1 3914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.